March 10, 2017
(Scientific American) – Many serious diseases that can be screened for at birth are not included in standard newborn genetic tests. Full genome sequencing of newborns for existing and potential disorders is now technologically possible and might soon be economically feasible. Scientists are exploring whether the resulting flood of genetic information will help parents and physicians care for newborns—or add unnecessary anxiety, complexity and cost.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.